(E)-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-ol, 97%, 250mg

Formic acid, min. 98%, for synthesis, 2.5 l, glass packaging

5-Bromo-1,2-dihydropyrimidin-2-one hydrobromide, 97%, 500mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)non-8-enoic acid, 95.0%, 250mg

Bis(3-methoxyphenyl)amine, 95.0%, 1g

6-Cyano-2-(4-pyridyl)benzimidazole, 250mg

6,7-Dihydro-5H-[2]pyrindin-7-ylamine dihydrochloride, 98%, 250mg

N-Methoxy-N-methylcyclopropanecarboxamide, 95.0%, 10g

(4-(2-Hydroxyethoxy)phenyl)(phenyl)methanone, 97.0%, 10g

2-Amino-5-trifluoromethyl-1,3,4-oxadiazole, 97.0%, 1g

Tert-butyl (2-(2-aminophenoxy)ethyl)carbamate, 95%, 5g

2-(1H-1,2,4-Triazol-1-yl)ethan-1-ol, 95.0%, 1g

Benzyl (2-bromoethyl)carbamate, 95.0%, 100g